Back
Cognition Therapeutics Stock Predictions
Sponsored
CGTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
CGTX
Cognition Therapeutics
Last Price:
0.44
Seasonality Move:
26.59%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Cognition Therapeutics Stock Forecast
-
Is Cognition Therapeutics Stock Undervalued?
The current Cognition Therapeutics [CGTX] share price is $0.44. The Score for CGTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - CGTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cognition Therapeutics Stock Go Up Next Year?
Data Unavailable
Cognition Therapeutics Stock Rating
Data Unavailable
Cognition Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cogrx.com
52-Week Data
52-Week High:
2.95
52-Week Low:
0.34
Prediction Charts
Market Cap:
18.27M
Price in USD:
0.44
Volume:
503.16K
Beta:
1.33
Technical Analysis
SMA50:
0.49
SMA100:
0.82
SMA200:
1.40
52-Wk Change:
-56.02%
Stock Predictions
-
Is Cognition Therapeutics stock public?
Yes, Cognition Therapeutics is a publicly traded company. -
What is the Cognition Therapeutics stock quote today?
The Cognition Therapeutics stock price is 0.44 USD today. -
How to buy Cognition Therapeutics stock online?
You can buy Cognition Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-4 | 0.47 | 0.47 | 0.49 | 0.44 |
Nov-5 | 0.47 | 0.49 | 0.51 | 0.47 |
Nov-6 | 0.52 | 0.50 | 0.52 | 0.49 |
Nov-7 | 0.52 | 0.52 | 0.53 | 0.51 |
Nov-8 | 0.50 | 0.51 | 0.52 | 0.50 |
Nov-11 | 0.51 | 0.51 | 0.52 | 0.48 |
Nov-12 | 0.51 | 0.60 | 0.62 | 0.50 |
Nov-13 | 0.60 | 0.54 | 0.60 | 0.53 |
Nov-14 | 0.53 | 0.51 | 0.54 | 0.50 |
Nov-15 | 0.50 | 0.46 | 0.51 | 0.46 |
Nov-18 | 0.48 | 0.46 | 0.49 | 0.46 |
Nov-19 | 0.45 | 0.44 | 0.46 | 0.43 |
Nov-20 | 0.44 | 0.44 | 0.47 | 0.43 |
Nov-21 | 0.44 | 0.44 | 0.45 | 0.43 |
Cognition Therapeutics Earnings
Data Unavailable
Cognition Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.16 per share.
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.